Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMDEVIMAB vs IMMUNE GLOBULIN NOS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMDEVIMAB vs IMMUNE GLOBULIN NOS: Safety Overview

Metric IMDEVIMAB IMMUNE GLOBULIN NOS
Total FAERS Reports 432 2,251
Deaths Reported 24 428
Death Rate 5.6% 19.0%
Hospitalizations 202 1,046
Average Patient Age 56.2 yrs 40.1 yrs
% Female Patients 52.7% 54.2%